Regenerative Medicine Foundation
  • Leadership
  • What We Do
    • Our Event History
    • Policy
    • Advocacy
    • Education & Outreach
  • Events
    • Upcoming Events
    • Past Events
      • World Stem Cell Summit
      • Regenerative Medicine and Stem Cell Action Awards
      • Regenerative Medicine Essentials
      • The “Art of Science” Inspires Students
      • Exploring Public Policy: Regenerative Medicine and Cell Therapies
      • Congressional Briefings
      • World Stem Cell Summit – CHINA
  • Membership/Register
    • Membership
    • Amazon SMILE
  • News
    • News
    • Portraits of Hope
    • Video
    • Video Chats
  • Contact
  • Donate
Select Page
FDA, Patients, and Providers: A Brand New “Relation-shift.”

FDA, Patients, and Providers: A Brand New “Relation-shift.”

by Joseph Dawson | Aug 3, 2017 | News & Opinions

By Doug Oliver: I’m very positive about the future role of FDA in ensuring that stem cell and related therapies are safe and effective. And, because of that, I believe now is the appointed time for both patients AND therapy providers to be intentional in helping to...

Recent Posts

  • UC Berkeley researchers discover ancestor of gene-editing tool CRISPR
  • Could Inhaled Cell Therapy Change the Course of COPD?
  • Healthspan Action Coalition and Leading Italian Organizations Announce Global Collaboration
  • Launching “Healthspan for All” at the Translational Longevity Summit
  • 3D-printed spheroids enable dual bone and vascular tissue development
Tweets about @WSCSummit